ADAM9 and neoplasm: Notably, platelet glycoprotein VI (GPVI) interacts with tumor-derived galectin 3 [89], integrin α6β1 binds to tumor ADAM9 [90], CLEC-2 recognizes tumor podoplanin [91], and GPIIb/IIIa associates with tumor ανβ3 integrin [92].